BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 26824999)

  • 1. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis.
    Tanaka R; Ichimura Y; Kubota N; Konishi R; Nakamura Y; Mizuno S; Takahashi S; Fujimoto M; Nomura T; Okiyama N
    J Invest Dermatol; 2022 Dec; 142(12):3167-3174.e9. PubMed ID: 35803322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 is required for activation of a unique subset of interleukin-17A-producing γδ T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection.
    Guo Y; Sun X; Shibata K; Yamada H; Muta H; Podack ER; Yoshikai Y
    Infect Immun; 2013 Oct; 81(10):3923-34. PubMed ID: 23918785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells.
    Nakamizo S; Honda T; Adachi A; Nagatake T; Kunisawa J; Kitoh A; Otsuka A; Dainichi T; Nomura T; Ginhoux F; Ikuta K; Egawa G; Kabashima K
    Sci Rep; 2017 Oct; 7(1):14076. PubMed ID: 29074858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vγ4+ γδ T Cells.
    Dhillon-LaBrooy A; Braband KL; Tantawy E; Rampoldi F; Kao YS; Boukhallouk F; Velasquez LN; Mamareli P; Silva L; Damasceno LEA; Weidenthaler-Barth B; Berod L; Almeida L; Sparwasser T
    J Invest Dermatol; 2024 Apr; 144(4):844-854.e2. PubMed ID: 37832844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
    Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
    J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
    Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
    J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
    Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
    Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
    Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
    Sun J; Zhao Y; Hu J
    PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant programmed cell death 1 inhibits psoriatic inflammation in imiquimod‑treated mice.
    Peng S; Cao M; Sun X; Zhou Y; Chen CY; Ma T; Li H; Li B; Zhu B; Li X
    Int J Mol Med; 2020 Aug; 46(2):869-879. PubMed ID: 32468061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch-Hes1 Signaling Regulates IL-17A
    Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
    Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.